Skip to main content
. 2012 Mar 23;33(6):1219–1224. doi: 10.1093/carcin/bgs135

Fig. 2.

Fig. 2.

Frequency of the three specific HBX mutations 1753V, 1762T/1764A and 1809A in genotypes A and E. Mutations 1753V and 1762T/1764A are present in >50% and 70% of subjects with no difference between genotypes. On the contrary, a higher proportion of 1809A mutations was observed in genotype A compared with genotype E (***P < 0.001).